Impact of Timing for Intra-Aortic Balloon Pump Insertion on Patients Undergoing Mitral Valve Surgery
The final, formatted version of the article will be published soon. Background: This study aimed to investigate the timing of intra-aortic balloon pump (IABP) insertion in patients undergoing mitral ...
Background: Acute mitral regurgitation (MR) is a critical condition that often necessitates urgent surgical intervention. While intra-aortic balloon pump (IABP) therapy is recommended as a bridge to ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Getinge announced today that European regulatory authorities reinstated the CE mark for its Cardiosave intra-aortic balloon pump. The Swedish medtech company faced a temporary suspension for the ...
1 Division of Cardiovascular Intensive Care, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan 2 Department of Cardiovascular Dynamics, National ...
IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ensure ...
"In short, it seems likely that the returned arterialized blood should be returned during diastole when the aortic valve is closed. This would probably offer less resistance to the ailing heart's ...
(RTTNews) - Teleflex (TFX) announced FDA 510(k) clearance of the AC3 Range Intra-Aortic Balloon Pump. The AC3 Range IABP is designed to provide ongoing IABP support across various patient transport ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results